Cannabis use, anxiety and depression are all on the rise in Canada: study – CTV News” style=”width:100%;max-height:420px;object-fit:cover;border-radius:8px;display:block;” />#68 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
I’d be happy to write those sentences, but I don’t see the article summary provided in your message. Could you please share the summary text so I can explain its clinical relevance?
A Canadian epidemiological study reports concurrent increases in cannabis use, anxiety disorders, and depression across the population, raising questions about potential associations between these trends. The research documents that cannabis use has risen substantially following legalization, while simultaneously anxiety and depression prevalence have increased, particularly among younger adults and certain demographic groups. While the study does not establish causality, it suggests clinicians should be alert to the possibility that cannabis use may be either a contributing factor to or a consequence of underlying anxiety and depression in their patients. These findings are particularly relevant for Canadian practitioners who now encounter patients with legal access to cannabis products and who may use them for self-management of mental health symptoms without medical supervision. The data underscore the importance of screening for both cannabis use and mood or anxiety disorders during routine clinical assessment, as patients may not spontaneously disclose either condition. Clinicians should counsel patients that while some individuals use cannabis to manage anxiety or depression, the evidence for efficacy is limited and regular use may paradoxically worsen these conditions over time.
“What we’re seeing in the data is that people are using cannabis to self-medicate anxiety and depression, but the evidence shows regular use actually worsens these conditions over time, particularly in younger patients whose prefrontal cortex is still developing. As clinicians, we need to screen for mood and anxiety disorders first and offer evidence-based treatments like SSRIs or therapy before cannabis becomes the default coping mechanism.”
💭 The concurrent rise in cannabis use, anxiety, and depression reported in Canadian population data presents a clinically relevant observation that warrants careful interpretation in primary care and mental health settings. While the temporal association is notable, the directional relationship remains unclear—cannabis use may contribute to or exacerbate anxiety and depression in some individuals, while others may use cannabis as self-medication for underlying mood or anxiety symptoms, creating a complex bidirectional relationship. Confounders such as socioeconomic stress, social isolation, access to mental health services, and substance use patterns complicate any causal inference from population-level trends alone. Given this uncertainty, clinicians should routinely screen for both cannabis use and mood or anxiety symptoms in their patient encounters, particularly among younger populations where cannabis use is increasing, and discuss the potential risks of cannabis for mental health outcomes without assuming a uniform effect across all patients. Personalizing the discussion to individual risk factors and monitoring for symptom
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
